Evidence map›Paper›PMID 40966513›Full record

ArticleNucleic acids research2025

In vivo pathway optimization in yeast via loxpsym-mediated shuffling of upstream activating sequences.

Ciaran Ruehmkorff, Ali Tafazoli Yazdi, Lena Hochrein

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ciaran RuehmkorffUniversity of Potsdam, Institute of Biochemistry and Biology, Karl-Liebknecht-Straße 24-25, Potsdam 14476, Germany.ORCID 0009-0008-5647-5714
Ali Tafazoli YazdiUniversity of Potsdam, Institute of Biochemistry and Biology, Karl-Liebknecht-Straße 24-25, Potsdam 14476, Germany.ORCID 0009-0006-8982-0129
Lena HochreinUniversity of Potsdam, Institute of Biochemistry and Biology, Karl-Liebknecht-Straße 24-25, Potsdam 14476, Germany.ORCID 0000-0002-2548-4318

Funding

European Regional Development FundEuropean Union's Horizon 2020Federal Ministry of Education and Research 031B1390PlantaSYST 664 620PlantaSYST 739 582
6 · The paper itself

Abstract

The budding yeast Saccharomyces cerevisiae plays an integral role in the bioeconomy as a powerful host for industrial bio-manufacturing, driving the production of diverse bio-based products. Achieving optimal product yields requires precise fine-tuning of the expression levels of multiple pathway genes, which often relies on cloning-intensive methods. Here, we present PULSE, an in vivo promoter engineering tool based on a streamlined workflow combining FACS-based screening of a randomized DNA library to identify active promoter elements, and their subsequent assembly into synthetic hybrid promoters where each element is flanked by loxPsym sites. Multiple promoter cassettes can be genome-integrated to generate "ready-to-use" platform strains, allowing users to easily place their genes of interest under the control of PULSE promoters. By activating Cre-mediated recombination, loxPsym-flanked promoter elements can be recombined, effectively bringing the target genes under control of a vast set of promoters spanning a wide range of expression levels in one simple step. Applying PULSE on two heterologous pathways, an eight-fold increase in β-carotene production and improved growth on high xylose concentrations by Saccharomyces cerevisiae was achieved. These results demonstrate the power and efficiency of PULSE as a versatile platform for metabolic engineering, enabling rapid, cloning-free optimization of biosynthetic pathways in vivo.

Indexed as

DNA ShufflingMetabolic EngineeringPromoter Regions, GeneticSaccharomyces cerevisiaebeta CaroteneGene Expression Regulation, FungalIntegrasesRecombination, GeneticXylosebeta CaroteneCre recombinaseIntegrasesXylose

Identifiers

PMID40966513
PMCPMC12448870

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.